MindRank AI (德睿智药)

MindRank AI (德睿智药) focuses on the research and development of new AI drugs, and has a one-stop AI-driven drug discovery platform-the medical knowledge graph PharmKG™️ and the drug design platform Molecule Pro™️. In 2018, the De Rui Zhi Pharmaceutical team has begun technical research and development, perfecting and verifying the capabilities of the self-developed artificial intelligence pharmaceutical platform. The team returned to China in November 2020 and established De Rui Zhiyao in Hangzhou, hoping to bring the mature one-stop AI drug research and development technology and development model back to China, and quickly start the commercialization cooperation and pipeline development of the platform.

61.8logo
logo
logo
logo
logo
logo
61.8
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 20.00 M
$ 27.07 M
Funding
$ 20.00 M
$ 27.07 M
Statistics
logo
NA
Action

MindRank AI (德睿智药) focuses on the research and development of new AI drugs, and has a one-stop AI-driven drug discovery platform-the medical knowledge graph PharmKG™️ and the drug design platform Molecule Pro™️. In 2018, the De Rui Zhi Pharmaceutical team has begun technical research and development, perfecting and verifying the capabilities of the self-developed artificial intelligence pharmaceutical platform. The team returned to China in November 2020 and established De Rui Zhiyao in Hangzhou, hoping to bring the mature one-stop AI drug research and development technology and development model back to China, and quickly start the commercialization cooperation and pipeline development of the platform.

0and0